PFIZER INC.

PFIZER INC. logo
🇺🇸United States
Ownership
Public
Established
1849-01-01
Employees
88K
Market Cap
$163.3B
Website
http://www.pfizer.com
Clinical Trials
Related News

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

First Posted Date
2023-04-03
Last Posted Date
2024-08-26
Lead Sponsor
Pfizer
Target Recruit Count
1000
Registration Number
NCT05796245
Locations
🇯🇵

Pfizer, Tokyo, Japan

A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults

First Posted Date
2023-03-28
Last Posted Date
2024-11-22
Lead Sponsor
Pfizer
Target Recruit Count
508
Registration Number
NCT05788237
Locations
🇦🇷

Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

First Posted Date
2023-03-28
Last Posted Date
2024-11-15
Lead Sponsor
Pfizer
Target Recruit Count
16
Registration Number
NCT05788328
Locations
🇺🇸

Qps-Mra, Llc, South Miami, Florida, United States

A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.

Completed
Conditions
Breast Cancer
First Posted Date
2023-03-15
Last Posted Date
2024-07-22
Lead Sponsor
Pfizer
Target Recruit Count
48
Registration Number
NCT05770713
Locations
🇨🇦

Pfizer Canada, Kirkland, Quebec, Canada

A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.

First Posted Date
2023-03-14
Last Posted Date
2023-07-12
Lead Sponsor
Pfizer
Target Recruit Count
18
Registration Number
NCT05767905
Locations
🇺🇸

New Haven Clinical Research Unit, New Haven, Connecticut, United States

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

First Posted Date
2023-03-06
Last Posted Date
2024-10-07
Lead Sponsor
Pfizer
Target Recruit Count
375
Registration Number
NCT05754710
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

First Posted Date
2023-02-28
Last Posted Date
2024-11-13
Lead Sponsor
Pfizer
Target Recruit Count
100
Registration Number
NCT05748171
Locations
🇫🇷

Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France

🇩🇪

Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-holstein, Germany

🇩🇰

Rigshospitalet, Copenhagen, Hovedstaden, Denmark

and more 71 locations

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

First Posted Date
2023-02-27
Last Posted Date
2023-06-27
Lead Sponsor
Pfizer
Target Recruit Count
16
Registration Number
NCT05745701
Locations
🇺🇸

New Haven Clinical Research Unit, New Haven, Connecticut, United States

A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

First Posted Date
2023-02-27
Last Posted Date
2024-08-05
Lead Sponsor
Pfizer
Target Recruit Count
376
Registration Number
NCT05745142
Locations
🇹🇷

Pfizer, Istanbul, Turkey

A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases

First Posted Date
2023-02-23
Last Posted Date
2024-12-18
Lead Sponsor
Pfizer
Target Recruit Count
250
Registration Number
NCT05742217
Locations
🇮🇹

IRST, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), Italy

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy